DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Research & Reports

Searching in Medtech (427)

Renal Denervation: Medtech’s Next Big Thing?

Renal Denervation: Medtech’s Next Big Thing?

Thank you!

Your request has been received by DRG. A represantative will contact you shortly to provide more details on the research and data contained in this report and ensure that it will meet your current research needs.

DRG’s new Physician Forum study provides a market assessment of the emerging renal denervation technology for device-based treatment of hypertension. This study surveyed 146 physicians—including general cardiologists, hypertension specialists, interventional cardiologists, and interventional radiologists in the US and Europe—who are performing renal denervation procedures, will be performing these procedures, or will be referring patients for renal denervation treatment. Respondents identified current procedure usage, future procedure opportunity, potential procedure drivers and limiters, and key device characteristics of renal denervation devices.

  • Pub Date: July 2012

Request report

Related reports:
You may also be interested in: